SGH LIMITED (SGH)
Latest AI Signal: SELL
Status: EXPIRED
Days Old: 23
Confidence: 75.00%
Date: 28-04-2026
Price: $39.410
Last Price: $41.450
Post-Signal Low Price: $38.100
Latest SGH LIMITED(SGH) News
29 Apr 2026, 10:37 AM
Let's talk about the popular SGH Limited (ASX:SGH). The company's shares received a lot of attention from a substantial price movement on the ASX over the last few months, increasing to AU$50.91 at one point, and dropping to the lows of AU$38.67. Some share price movements can give investors a bette
12 Mar 2026, 07:09 AM
We recently published 9Â Best Aluminum and Aluminum Mining Stocks to Invest In. Steel Dynamics, Inc. (NASDAQ:STLD) is one of the best aluminum and aluminum mining stocks to invest in.
Steel manufacturer and aluminum recycler Steel Dynamics, Inc. (NASDAQ:STLD)’s shares were on banking giant Wells Far
02 Nov 2025, 09:36 AM
SGH (ASX:SGH) has had a rough three months with its share price down 4.4%. It is possible that the markets have ignored the company's differing financials and decided to lean-in to the negative sentiment. Fundamentals usually dictate market outcomes so it makes sense to study the company's financial
16 Oct 2025, 11:15 AM
Looking at SGH Limited's (ASX:SGH ) insider transactions over the last year, we can see that insiders were net buyers. That is, there were more number of shares purchased by insiders than there were sold.
While insider transactions are not the most important thing when it comes to long-term investi
Sell Confidence High
AI Confidence - 75.00 % model confidence
Business Overview
SGH Limited is a Singapore-based company primarily engaged in healthcare services including hospital management, medical diagnostics, and specialty clinics. It holds a significant market position in the regional healthcare sector, leveraging its integrated healthcare network to serve a broad patient base.
Financial Analysis
| Cash Flow | Moderate |
| Debt | Moderate |
| Profitability | Moderate |
| Revenue Trend | Flat |
Technical Analysis
| Trend | Bearish |
| Momentum | Weak |
| RSI Signal | Neutral |
| Support Level | $ 38.00 |
| Resistance Level | $ 41.50 |
Valuation
Valuation - Fairly Valued
Current price reflects stable earnings but limited growth prospects amid sector challenges.
Catalysts
• Potential expansion into new regional markets could drive growth.
• Introduction of innovative healthcare services or partnerships.
Recommendation
Action - Sell
Timeframe - Short Term
Given the flat revenue trend, moderate profitability, and bearish technical signals, SGH appears to face near-term headwinds. Investors should consider reducing exposure due to limited upside catalysts and potential margin pressures.